104 related articles for article (PubMed ID: 38746375)
1. Discovery of CRBN-dependent WEE1 Molecular Glue Degraders from a Multicomponent Combinatorial Library.
Razumkov H; Jiang Z; Baek K; You I; Geng Q; Donovan KA; Tang MT; Metivier RJ; Mageed N; Seo P; Li Z; Byun WS; Hinshaw SM; Sarott RC; Fischer ES; Gray NS
bioRxiv; 2024 May; ():. PubMed ID: 38746375
[TBL] [Abstract][Full Text] [Related]
2. Selective CK1α degraders exert antiproliferative activity against a broad range of human cancer cell lines.
Nishiguchi G; Mascibroda LG; Young SM; Caine EA; Abdelhamed S; Kooijman JJ; Miller DJ; Das S; McGowan K; Mayasundari A; Shi Z; Barajas JM; Hiltenbrand R; Aggarwal A; Chang Y; Mishra V; Narina S; Thomas M; Loughran AJ; Kalathur R; Yu K; Zhou S; Wang X; High AA; Peng J; Pruett-Miller SM; Daniels DL; Urh M; Shelat AA; Mullighan CG; Riching KM; Zaman GJR; Fischer M; Klco JM; Rankovic Z
Nat Commun; 2024 Jan; 15(1):482. PubMed ID: 38228616
[TBL] [Abstract][Full Text] [Related]
3. Cereblon target validation using a covalent inhibitor of neosubstrate recruitment.
Dann GP; Liu H; Nowak RP; Jones LH
Methods Enzymol; 2023; 681():155-167. PubMed ID: 36764755
[TBL] [Abstract][Full Text] [Related]
4. Protein degraders - from thalidomide to new PROTACs.
Ito T
J Biochem; 2024 Apr; 175(5):507-519. PubMed ID: 38140952
[TBL] [Abstract][Full Text] [Related]
5. Selective degradation-inducing probes for studying cereblon (CRBN) biology.
Powell CE; Du G; Bushman JW; He Z; Zhang T; Fischer ES; Gray NS
RSC Med Chem; 2021 Aug; 12(8):1381-1390. PubMed ID: 34458741
[TBL] [Abstract][Full Text] [Related]
6. Development of PDE6D and CK1α Degraders through Chemical Derivatization of FPFT-2216.
Teng M; Lu W; Donovan KA; Sun J; Krupnick NM; Nowak RP; Li YD; Sperling AS; Zhang T; Ebert BL; Fischer ES; Gray NS
J Med Chem; 2022 Jan; 65(1):747-756. PubMed ID: 34965125
[TBL] [Abstract][Full Text] [Related]
7. Lessons from natural molecular glue degraders.
Cao S
Biochem Soc Trans; 2024 Jun; ():. PubMed ID: 38864421
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of Wee1 kinase degraders.
Zhu S; Liu J; Xiao D; Wang P; Ma J; Hu X; Fu J; Zhou Y; Li J; Lu W
Eur J Med Chem; 2022 Dec; 243():114786. PubMed ID: 36170799
[TBL] [Abstract][Full Text] [Related]
9. From Thalidomide to Rational Molecular Glue Design for Targeted Protein Degradation.
Oleinikovas V; Gainza P; Ryckmans T; Fasching B; Thomä NH
Annu Rev Pharmacol Toxicol; 2024 Jan; 64():291-312. PubMed ID: 37585660
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of novel glutarimide ligands for the E3 ligase substrate receptor Cereblon (CRBN): Investigation of their binding mode and antiproliferative effects against myeloma cell lines.
Krasavin M; Adamchik M; Bubyrev A; Heim C; Maiwald S; Zhukovsky D; Zhmurov P; Bunev A; Hartmann MD
Eur J Med Chem; 2023 Jan; 246():114990. PubMed ID: 36476642
[TBL] [Abstract][Full Text] [Related]
11. Exploiting ubiquitin ligase cereblon as a target for small-molecule compounds in medicine and chemical biology.
Ito T; Yamaguchi Y; Handa H
Cell Chem Biol; 2021 Jul; 28(7):987-999. PubMed ID: 34033753
[TBL] [Abstract][Full Text] [Related]
12. Synthetic and Medicinal Chemistry Approaches Toward WEE1 Kinase Inhibitors and Its Degraders.
Alli VJ; Yadav P; Suresh V; Jadav SS
ACS Omega; 2023 Jun; 8(23):20196-20233. PubMed ID: 37323408
[TBL] [Abstract][Full Text] [Related]
13. Emerging mechanisms of targeted protein degradation by molecular glues.
Frere GA; de Araujo ED; Gunning PT
Methods Cell Biol; 2022; 169():1-26. PubMed ID: 35623698
[TBL] [Abstract][Full Text] [Related]
14. Development of Phenyl-substituted Isoindolinone- and Benzimidazole-type Cereblon Ligands for Targeted Protein Degradation.
Nie X; Zhao Y; Tang H; Zhang Z; Liao J; Almodovar-Rivera CM; Sundaresan R; Xie H; Guo L; Wang B; Guan H; Xing Y; Tang W
Chembiochem; 2024 Feb; 25(4):e202300685. PubMed ID: 38116854
[TBL] [Abstract][Full Text] [Related]
15. Selective Wee1 degradation by PROTAC degraders recruiting VHL and CRBN E3 ubiquitin ligases.
Aublette MC; Harrison TA; Thorpe EJ; Gadd MS
Bioorg Med Chem Lett; 2022 May; 64():128636. PubMed ID: 35231578
[TBL] [Abstract][Full Text] [Related]
16. Dual IKZF2 and CK1α degrader targets acute myeloid leukemia cells.
Park SM; Miyamoto DK; Han GYQ; Chan M; Curnutt NM; Tran NL; Velleca A; Kim JH; Schurer A; Chang K; Xu W; Kharas MG; Woo CM
Cancer Cell; 2023 Apr; 41(4):726-739.e11. PubMed ID: 36898380
[TBL] [Abstract][Full Text] [Related]
17. Development and Characterization of a Wee1 Kinase Degrader.
Li Z; Pinch BJ; Olson CM; Donovan KA; Nowak RP; Mills CE; Scott DA; Doctor ZM; Eleuteri NA; Chung M; Sorger PK; Fischer ES; Gray NS
Cell Chem Biol; 2020 Jan; 27(1):57-65.e9. PubMed ID: 31735695
[TBL] [Abstract][Full Text] [Related]
18. Structural basis of lenalidomide-induced CK1α degradation by the CRL4(CRBN) ubiquitin ligase.
Petzold G; Fischer ES; Thomä NH
Nature; 2016 Apr; 532(7597):127-30. PubMed ID: 26909574
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Potent Degraders of the Dengue Virus Envelope Protein.
Li Z; Liu HY; He Z; Chakravarty A; Golden RP; Jiang Z; You I; Yue H; Donovan KA; Du G; Che J; Tse J; Che I; Lu W; Fischer ES; Zhang T; Gray NS; Yang PL
bioRxiv; 2024 Jun; ():. PubMed ID: 38854003
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of cereblon-based drugs.
Asatsuma-Okumura T; Ito T; Handa H
Pharmacol Ther; 2019 Oct; 202():132-139. PubMed ID: 31202702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
